
zzso zzso has been combined in the past with other drugs for the combination chemotherapy for zzso of the breast, zzso and zzso These drug regimens were limited by the fact that zzso fails to kill zzso cancer cells at the doses that are safe to zzso The goal of the present study is to test the feasibility of replacing zzso in established zzso combination chemotherapy with the zzso zzso system for the purpose of reducing toxicity and increasing zzso 

We have replaced zzso in the weekly combination of zzso zzso acid zzso and zzso chemotherapy by zzso and an zzso zzso that carries the zzso zzso zzso zzso zzso unit zzso the zzso zzso gene linked to the zzso gene by an internal zzso entry site zzso This combination is called zzso combination zzso The goal of using the zzso was to decrease the toxicity to normal tissue and to increase the efficacy of therapy in the cancer cells by increasing the concentration of zzso sufficiently high that even zzso cancer cells would be killed by zzso through its incorporation into zzso and zzso zzso of synthesis of functional zzso We compared the in zzso efficacy of the genetic combination therapy with the conventional combination chemotherapy in a mouse colon cancer zzso 

Both zzso and zzso zzso zzso carrying an zzso zzso zzso zzso unit when combined with zzso zzso and zzso showed increased in zzso therapeutic activity that was significantly higher than that of the conventional chemotherapy zzso zzso mice treated with the genetic combination therapy showed a statistically significant advantage in terms of increased response rate, response zzso survival, and reduced toxicity when compared with zzso mice treated with the conventional combination zzso 

Replacement of zzso in zzso combination chemotherapy with the zzso zzso and zzso reduces toxicity and increases zzso This is a concept that could be potentially applied widely for many forms of cancer zzso 

